Skip to main content
TipRanks
Go Ultimate75% OFF

Xeris Pharmaceuticals (0A8E) Ownership - Who Owns Xeris Pharmaceuticals?

0 Followers

Xeris Pharmaceuticals (0A8E) Ownership Overview

  • 4.85% Insiders
  • 12.17% Mutual Funds
  • 18.25% Other Institutional Investors
  • 13.97% ETFs
  • 50.75% Public Companies and Individual Investors

The ownership structure of Xeris Pharmaceuticals (GB:0A8E) stock is a mix of institutional, retail, and individual investors. Approximately 44.40% of the company’s stock is owned by Institutional Investors, 4.85% is owned by Insiders, and 50.75% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Dec 18, 2025John Johnson$976,234

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Deerfield Management Company, Lp$410,005
Dec 31, 2025Entrypoint Capital, Llc$534,451
Dec 31, 2025Driehaus Capital Management Llc$23,397,450

Top Shareholders

GB:0A8E top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.14,659,299Institution8.02%245,176,776
Vanguard8,212,872Institution4.50%137,360,284
Ishares8,124,706Institution4.45%135,885,708
Vanguard Index Funds7,180,117Institution3.93%120,087,457
John Patrick Shannon2,898,933Insider1.59%48,484,654
Tiaa-cref Funds2,731,436Institution1.50%45,683,267
Fidelity Salem Street Trust2,055,229Institution1.12%34,373,705
Spdr2,017,832Institution1.10%33,748,240
Fidelity Concord Street Trust1,769,397Institution0.97%29,593,165
Kevin Mcculloch1,584,208Insider0.87%26,495,879

Top Mutual Fund Holders

GB:0A8E top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds7,180,117Institution3.93%120,087,457
Tiaa-cref Funds2,731,436Institution1.50%45,683,267
Fidelity Salem Street Trust2,055,229Institution1.12%34,373,705
Fidelity Concord Street Trust1,769,397Institution0.97%29,593,165
Vanguard Scottsdale Funds1,183,316Institution0.65%19,790,960
Federated Hermes Mdt Series1,067,305Institution0.58%17,850,676
Schwab Capital Trust577,876Institution0.32%9,664,976
Dfa Investment Dimensions Group Inc530,141Institution0.29%8,866,608
Vanguard World Fund514,791Institution0.28%8,609,879
Vanguard Explorer Fund490,039Institution0.27%8,195,902

FAQ

Who Owns Xeris Pharmaceuticals (GB:0A8E)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 44.40% of the company's stock is held by institutional investors, 4.85% is held by insiders, and 50.75% is held by public companies and individual investors.
What percentage of Xeris Pharmaceuticals (GB:0A8E) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 44.40% of Xeris Pharmaceuticals (GB:0A8E) stock is held by institutional investors: 12.17% by mutual funds, 13.97% by ETFs and 18.25% by other institutional investors.
What percentage of Xeris Pharmaceuticals (GB:0A8E) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 50.75% of Xeris Pharmaceuticals (GB:0A8E) stock is held by public companies and individual investors.
Who owns the most shares of Xeris Pharmaceuticals (GB:0A8E)?
BlackRock, Inc. owns the most shares of Xeris Pharmaceuticals (GB:0A8E).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.